References

Citations

1. Centers for Disease Control and Prevention (2010). Prevention and control of influenza with vaccines: Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2010. MMWR, 59(RR-08): 1–62. Also available online: http://www.cdc.gov/mmwr/pdf/rr/rr5908.pdf. [Errata in MMWR, 59(31): 993 and MMWR, 59(35): 1147.]

2. Jefferson T (2009). Influenza, search date June 2008. Online version of BMJ Clinical Evidence: http://www.clinicalevidence.com.

3. Nichol KL, et al. (2007). Effectiveness of influenza vaccine in the community-dwelling elderly. New England Journal of Medicine, 357(14): 1373–1381.

4. Zaman K, et al. (2008). Effectiveness of maternal influenza immunization in mothers and infants. New England Journal of Medicine, 359(15): 1555–1564.

5. Leyer GJ, et al. (2009). Probiotic effects on cold and influenza-like symptom incidence and duration in children. Pediatrics, 124(2): e172–e179.

6. Centers for Disease Control and Prevention (2006). CDC Health Alert: CDC Recommends Against the Use of Amantadine and Rimantadine for the Treatment or Prophylaxis of Influenza in the United States During the 2005–06 Influenza Season. Available online: http://www.cdc.gov/flu/han011406.htm.

7. Cooper NJ, et al. (2003). Effectiveness of neuraminidase inhibitors in treatment and prevention of influenza A and B: Systematic review and meta-analyses of randomised controlled trials. BMJ, 326(7401): 1235.

Other Works Consulted

• U.S. Centers for Disease Control and Prevention (2011). Maternal and infant outcomes among severely ill pregnant and postpartum women with 2009 pandemic influenza A (H1N1)—United States, April 2009–August 2010. Morbidity and Mortality Weekly Report, 60(35): 1193–1196.